Henry Schein Dental Company is a leading provider of dental products and services, catering primarily to dental professionals and practices. The company offers a comprehensive range of solutions including dental equipment, consumable supplies, technology products, and practice management tools. In addition to its product offerings, Henry Schein Dental also provides training and support services, helping dental practitioners enhance their operations and improve patient care. With a strong emphasis on innovation and customer service, the company plays a vital role in advancing the dental industry and supporting the success of dental health providers. Read More
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC)
jumped 4.8% in the afternoon session after the company reported decent fourth-quarter 2025 financial results where revenue surpassed Wall Street's expectations, but earnings fell short. The dental and medical products distributor posted quarterly sales of $3.44 billion, a 7.7% increase year on year that beat analyst forecasts. Investors appeared to focus on the strong top-line performance, which was supported by a 4.9% rise in organic revenue. However, the results were not entirely positive, as the company's GAAP profit of $0.85 per share missed Wall Street's consensus estimates by 16.4%. Overall, the market's positive reaction suggests that the better-than-expected sales outweighed the disappointment from the earnings miss for the quarter.
Dental and medical products company Henry Schein (NASDAQ:HSIC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $3.44 billion. Its GAAP profit of $0.85 per share was 16.4% below analysts’ consensus estimates.
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter ended December 27, 2025.
Henry Schein One, the market leader in dental practice management systems, today announced the launch of AI-driven Image Verify, the latest innovation in a rapid series of product advancements designed to deliver the cleanest claims experience in dentistry. Image Verify, natively embedded in Dentrix and Dentrix Ascend, represents another major step towards the company’s bold Clean Claims vision – a future where dental practices submit claims once and never have to touch them again.
Henry Schein One today announced a direct data integration between Align Technology’s iTero™ intraoral scanners and its core practice management platforms—Dentrix, Dentrix Ascend, and Dentally—creating a seamless connection between digital scanning, diagnosis, and daily operations for practices worldwide.
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile® (GKAS) 2026 at UTHealth Houston School of Dentistry, marking 24 years of transforming children’s lives through this access-to-oral-health-care initiative. What began as a local grassroots movement in St. Louis, MO, has evolved into a national movement, having served more than 10.2 million underserved children since 2003. GKAS begins nationally in February, which is National Children’s Dental Health Month, and events will take place year-round. These essential oral health services are made possible thanks to the tens of thousands of dental professionals who volunteer their time and talent.
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its fourth quarter 2025 financial results before the stock market opens on Tuesday, February 24, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, and Ronald N. South, Senior Vice President and Chief Financial Officer.
Henry Schein trades at $76.27 per share and has stayed right on track with the overall market, gaining 8% over the last six months. At the same time, the S&P 500 has returned 11.5%.
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer (“CEO”), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and effective leadership transition.
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Envista (NYSE:NVST) and its peers.
An improving earnings profile, aggressive buybacks, and a renewed focus on margins might be changing how long-term investors think about this healthcare distributor.
Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in January:
Henry Schein, Inc. (Nasdaq: HSIC) (the “Company”), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that it expects to appoint the Company’s next CEO by mid-January 2026.
In a stunning return to the public stage, Medline Industries (Nasdaq: MDLN) successfully executed the largest initial public offering (IPO) in the United States since 2021, pricing its shares at the top of its range and witnessing a massive first-day "pop" that has sent ripples through the financial world. The
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street.
Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
